Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships
09 janv. 2025 08h30 HE
|
Oribiotech Ltd
Ori Biotech announces the appointment of two new members to its senior team and new members to its Strategic Advisory Board (SAB).
Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
07 janv. 2025 09h00 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers
07 janv. 2025 08h30 HE
|
Ori Biotech Ltd
Ori Biotech announces the first customer deliveries of the IRO® platform, designed to help address the current challenges in CGT manufacturing.
Making Cancer Drugs Safer: CellMosaic CEO to Host Live Investment Webinar
31 déc. 2024 07h52 HE
|
CellMosaic
Woburn, MA, Dec. 31, 2024 (GLOBE NEWSWIRE) -- CellMosaic CEO Dr. Yumei Huang will host a live presentation and Q&A on January 7 at 2:00 PM EST to discuss how the company's breakthrough...
NTHU Researchers Unveil the Mystery of Cancer Cells' Sugar Addiction
19 déc. 2024 10h00 HE
|
NATIONAL TSING HUA UNIVERSITY
NTHU researchers uncover how cancer cells’ sugar addiction fuels growth, paving the way for potential new cancer treatments.
Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
19 déc. 2024 09h00 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
5. Jubiläum: Die ICPO Foundation gestaltet eine neue Ära der Krebsbehandlung mit Radiotheranostik für Patienten weltweit
12 déc. 2024 04h00 HE
|
ICPO Foundation
Mit der Einführung der "ICPO Academy for Theranostics" und dem Aufbau eines globalen Netzwerks von ICPO-Centern hat sich die Foundation als international führend in der Wissensvermittlung und der...
5th Anniversary: ICPO Foundation is empowering a new era of cancer treatment with Radiotheranostics for patients worldwide
12 déc. 2024 04h00 HE
|
ICPO Foundation
Launching the "ICPO Academy for Theranostics" and creating its global network of ICPO Centers, the foundation has become an international leader in sharing knowledge and shaping standards in its...
Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies
10 déc. 2024 08h31 HE
|
Ori Biotech Ltd
Ori Biotech and Fresenius Kabi partner to integrate Ori’s IRO® Platform with Cue® and Lovo® systems, advancing scalable cell and gene therapy manufacturing
Das ICPO Theranostics Virtual Summit 2024 präsentierte die heutige und zukünftige klinische Relevanz von Radiotheranostik in der Onkologie
27 nov. 2024 03h00 HE
|
ICPO Foundation
Ein wissenschaftliches Weltklasse-Programm, präsentiert von 35 internationalen Experten 27. November 2024 – Wiesbaden, Deutschland. Die International Centers for Precision Oncology Foundation (ICPO)...